Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Electrophysiological and pharmacological studies of a cloned human dopamine transporter (hDAT) were undertaken to investigate the mechanisms of transporter function and the actions of drugs at this target. Using two-electrode voltage-clamp techniques with hDAT-expressing Xenopus laevis oocytes, we show that hDAT can be considered electrogenic by two criteria. (1) Uptake of hDAT substrates gives rise to a pharmacologically appropriate "transport-associated" current. (2) The velocity of DA uptake measured in oocytes clamped at various membrane potentials was voltage-dependent, increasing with hyperpolarization. Concurrent measurement of transport-associated current and substrate flux in individual oocytes revealed that charge movement during substrate translocation was greater than would be expected for a transport mechanism with fixed stoichiometry of 2 Na+ and 1 Cl- per DA+ molecule. In addition to the transport-associated current, hDAT also mediates a constitutive leak current, the voltage and ionic dependencies of which differ markedly from those of the transport-associated current. Ion substitution experiments suggest that alkali cations and protons are carried by the hDAT leak conductance. In contrast to the transport-associated functions, the leak does not require Na+ or Cl-, and DAT ligands readily interact with the transporter even in the absence of these ions. The currents that hDAT mediates provide a functional assay that readily distinguishes the modes of action of amphetamine-like "DA-releasing" drugs from cocaine-like translocation blockers. In addition, the voltage dependence of DA uptake suggests a mechanism through which presynaptic DA autoreceptor activation may accelerate the termination of dopaminergic neurotransmission in vivo.
Amara,
Neurotransmitter transporters: recent progress.
1993,
Pubmed Arriza,
Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex.
1994,
Pubmed
,
Xenbase Baldessarini,
The uptake and subcellular distribution of aromatic amines in the brain of the rat.
1971,
Pubmed Bauman,
Is drug inhibition of dopamine uptake a misinterpretation of in vitro experiments?
,
Pubmed Bonnet,
Simultaneous evaluation by a double labelling method of drug-induced uptake inhibition and release of dopamine in synaptosomal preparation of rat striatum.
1984,
Pubmed Buck,
Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium.
1994,
Pubmed Cammack,
A GABA transporter operates asymmetrically and with variable stoichiometry.
1994,
Pubmed Cammack,
Ions required for the electrogenic transport of GABA by horizontal cells of the catfish retina.
1993,
Pubmed Cammack,
Channel behavior in a gamma-aminobutyrate transporter.
1996,
Pubmed Cass,
Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake.
1994,
Pubmed Cerruti,
Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain.
1993,
Pubmed Chang,
The mechanism of action of MPTP and MPP+ on endogenous dopamine release from the rat corpus striatum superfused in vitro.
1986,
Pubmed Chen,
Thermodynamic determination of the Na+: glucose coupling ratio for the human SGLT1 cotransporter.
1995,
Pubmed
,
Xenbase Chomczynski,
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
1987,
Pubmed Ciliax,
The dopamine transporter: immunochemical characterization and localization in brain.
1995,
Pubmed Costa,
Determination of ionic permeability coefficients of the plasma membrane of Xenopus laevis oocytes under voltage clamp.
1989,
Pubmed
,
Xenbase Dascal,
The use of Xenopus oocytes for the study of ion channels.
1987,
Pubmed
,
Xenbase DeCoursey,
Voltage-activated hydrogen ion currents.
1994,
Pubmed DeFelice,
Pore models for transporters?
1996,
Pubmed Dorris,
Amine uptake and storage mechanisms in the corpus striatum of rat and rabbit.
1971,
Pubmed Eliasof,
Retinal glial cell glutamate transporter is coupled to an anionic conductance.
1996,
Pubmed Eshleman,
Characterization of a recombinant human dopamine transporter in multiple cell lines.
1995,
Pubmed Fairman,
An excitatory amino-acid transporter with properties of a ligand-gated chloride channel.
1995,
Pubmed
,
Xenbase Fischer,
Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model.
1979,
Pubmed Galli,
Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants.
1995,
Pubmed Gerhardt,
Outflow and overflow of picogram levels of endogenous dopamine and DOPAC from rat striatal slices: improved methodology for studies of stimulus-evoked release and metabolism.
1989,
Pubmed Giros,
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.
1996,
Pubmed Giros,
Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.
1992,
Pubmed Giros,
Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters.
1994,
Pubmed Gu,
Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence.
1994,
Pubmed Heikkila,
Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices.
1975,
Pubmed Isaacson,
Local and diffuse synaptic actions of GABA in the hippocampus.
1993,
Pubmed Javitch,
[3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
1984,
Pubmed Kanner,
Mechanism of transport and storage of neurotransmitters.
1987,
Pubmed Keller,
Evidence for the release of 1-methyl-4-phenylpyridinium (MPP+) from rat striatal neurons in vitro.
1985,
Pubmed Krueger,
Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus.
1990,
Pubmed Lacey,
Neurotransmitter receptors and ionic conductances regulating the activity of neurones in substantia nigra pars compacta and ventral tegmental area.
1993,
Pubmed Langeloh,
The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: multifactorial induction of outward transport.
1987,
Pubmed Larsson,
Noise analysis of the glutamate-activated current in photoreceptors.
1996,
Pubmed Lester,
Permeation properties of neurotransmitter transporters.
1994,
Pubmed Liang,
Evidence for carrier-mediated efflux of dopamine from corpus striatum.
1982,
Pubmed Lorang,
Cell-type-specific expression of catecholamine transporters in the rat brain.
1994,
Pubmed Lukacs,
Proton conductance of the plasma membrane: properties, regulation, and functional role.
1993,
Pubmed Mager,
Ion binding and permeation at the GABA transporter GAT1.
1996,
Pubmed
,
Xenbase Mager,
Conducting states of a mammalian serotonin transporter.
1994,
Pubmed
,
Xenbase Maloney,
Bacterial transporters.
1994,
Pubmed McElvain,
A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine.
1992,
Pubmed Meiergerd,
D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo.
1993,
Pubmed Nestler,
Drug addiction: a model for the molecular basis of neural plasticity.
1993,
Pubmed Nirenberg,
The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons.
1996,
Pubmed Parent,
Electrogenic properties of the cloned Na+/glucose cotransporter: I. Voltage-clamp studies.
1992,
Pubmed
,
Xenbase Parker,
Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
1986,
Pubmed Parsons,
Co-administration of the D2 antagonist pimozide inhibits up-regulation of dopamine release and uptake induced by repeated cocaine.
1993,
Pubmed Pifl,
Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium.
1993,
Pubmed Pifl,
Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
1995,
Pubmed Pristupa,
Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
1994,
Pubmed Pulvirenti,
Dopamine receptor agonists, partial agonists and psychostimulant addiction.
1994,
Pubmed Raiteri,
Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine.
1979,
Pubmed Raiteri,
Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine.
1977,
Pubmed Risso,
Sodium-dependent GABA-induced currents in GAT1-transfected HeLa cells.
1996,
Pubmed Ritz,
Cocaine receptors on dopamine transporters are related to self-administration of cocaine.
1987,
Pubmed Rollema,
Brain dialysis in conscious rats reveals an instantaneous massive release of striatal dopamine in response to MPP+.
1986,
Pubmed Rudnick,
From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters.
1993,
Pubmed Seiden,
Amphetamine: effects on catecholamine systems and behavior.
1993,
Pubmed Sesack,
Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets.
1994,
Pubmed Sirinathsinghji,
Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
1988,
Pubmed Sonders,
Channels in transporters.
1996,
Pubmed Steinberg,
Effects of desmethylimipramine and cocaine on the uptake, retention and metabolism of H3-tyramine in rat brain slices.
1970,
Pubmed Sulzer,
Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport.
1995,
Pubmed Sulzer,
Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action.
1990,
Pubmed Turner,
Stoichiometry of cotransport systems.
1985,
Pubmed Umbach,
Intestinal Na+/glucose cotransporter expressed in Xenopus oocytes is electrogenic.
1990,
Pubmed
,
Xenbase Vandenberg,
Constitutive ion fluxes and substrate binding domains of human glutamate transporters.
1995,
Pubmed
,
Xenbase Vandenbergh,
A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs.
1992,
Pubmed Wadiche,
Ion fluxes associated with excitatory amino acid transport.
1995,
Pubmed
,
Xenbase Wall,
Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
1995,
Pubmed White,
Synaptic regulation of mesocorticolimbic dopamine neurons.
1996,
Pubmed Wise,
Addictive drugs and brain stimulation reward.
1996,
Pubmed Yung,
Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy.
1995,
Pubmed Zaczek,
Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport.
1991,
Pubmed
